These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12457721)
1. Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells. Mihara M; Shintani S; Nakashiro K; Hamakawa H Oral Oncol; 2003 Jan; 39(1):49-55. PubMed ID: 12457721 [TBL] [Abstract][Full Text] [Related]
2. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881 [TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells. Mihara M; Shintani S; Kiyota A; Matsumura T; Wong DT Int J Oncol; 2002 Jul; 21(1):95-101. PubMed ID: 12063555 [TBL] [Abstract][Full Text] [Related]
4. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031 [TBL] [Abstract][Full Text] [Related]
5. Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol. Li Y; Chinni SR; Senderowicz AM; Sarkar FH Int J Oncol; 2000 Oct; 17(4):755-9. PubMed ID: 10995888 [TBL] [Abstract][Full Text] [Related]
6. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. König A; Schwartz GK; Mohammad RM; Al-Katib A; Gabrilove JL Blood; 1997 Dec; 90(11):4307-12. PubMed ID: 9373241 [TBL] [Abstract][Full Text] [Related]
7. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. Wittmann S; Bali P; Donapaty S; Nimmanapalli R; Guo F; Yamaguchi H; Huang M; Jove R; Wang HG; Bhalla K Cancer Res; 2003 Jan; 63(1):93-9. PubMed ID: 12517783 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway. Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887 [TBL] [Abstract][Full Text] [Related]
9. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Raju U; Nakata E; Mason KA; Ang KK; Milas L Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657 [TBL] [Abstract][Full Text] [Related]
10. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines. Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542 [TBL] [Abstract][Full Text] [Related]
11. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Alonso M; Tamasdan C; Miller DC; Newcomb EW Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031 [TBL] [Abstract][Full Text] [Related]
12. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Gojo I; Zhang B; Fenton RG Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644 [TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. Dai Y; Rahmani M; Grant S Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039 [TBL] [Abstract][Full Text] [Related]
14. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma]. Song Y; Shen K; Tang PP Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904 [TBL] [Abstract][Full Text] [Related]
16. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol. Gao N; Dai Y; Rahmani M; Dent P; Grant S Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103 [TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridol. Semenov I; Akyuz C; Roginskaya V; Chauhan D; Corey SJ Leuk Res; 2002 Mar; 26(3):271-80. PubMed ID: 11792416 [TBL] [Abstract][Full Text] [Related]
18. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Senderowicz AM Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936 [TBL] [Abstract][Full Text] [Related]
19. Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. Senderowicz AM Invest New Drugs; 1999; 17(3):313-20. PubMed ID: 10665481 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]